170 related articles for article (PubMed ID: 2973061)
1. Peptide-mediated modulation of T-cell allorecognition.
Eckels DD; Gorski J; Rothbard J; Lamb JR
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
[TBL] [Abstract][Full Text] [Related]
3. The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function.
Lamb JR; Higgins JA; Hetzel C; Hayball JD; Lake RA; O'Hehir RE
Immunology; 1995 Jul; 85(3):447-54. PubMed ID: 7558134
[TBL] [Abstract][Full Text] [Related]
4. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
Eckels DD; Sell TW; Long EO; Sekaly RP
Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
[TBL] [Abstract][Full Text] [Related]
5. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
Geluk A; van Meijgaarden KE; Ottenhoff TH
Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
[TBL] [Abstract][Full Text] [Related]
6. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
7. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
9. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
10. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
11. The relationship between MHC restricted and allospecific T cell recognition.
Lechler R; Batchelor R; Lombardi G
Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
[TBL] [Abstract][Full Text] [Related]
12. Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells.
Sidhu S; Deacock S; Bal V; Batchelor JR; Lombardi G; Lechler RI
J Exp Med; 1992 Sep; 176(3):875-80. PubMed ID: 1512550
[TBL] [Abstract][Full Text] [Related]
13. Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes.
Eckels DD; Sell TW; Bronson SR; Johnson AH; Hartzman RJ; Lamb JR
Immunogenetics; 1984; 19(5):409-23. PubMed ID: 6202629
[TBL] [Abstract][Full Text] [Related]
14. T cell recognition of allopeptides in context of syngeneic MHC.
Liu Z; Braunstein NS; Suciu-Foca N
J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
[TBL] [Abstract][Full Text] [Related]
15. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
[TBL] [Abstract][Full Text] [Related]
17. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
19. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
Jardetzky TS; Gorga JC; Busch R; Rothbard J; Strominger JL; Wiley DC
EMBO J; 1990 Jun; 9(6):1797-803. PubMed ID: 2189723
[TBL] [Abstract][Full Text] [Related]
20. Allergy to antibiotics: T-cell recognition of amoxicillin is HLA-DR restricted and does not require antigen processing.
Horton H; Weston SD; Hewitt CR
Allergy; 1998 Jan; 53(1):83-8. PubMed ID: 9491234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
